Latest News

TILT preparations during the corona pandemic

TILT preparations during the corona pandemic

The ongoing pandemic affects TILT less than some other companies. This is because we don’t have regular sales. Instead, our operations are based on long term research and development. It is clear corona might cause unexpected delays in the upcoming year, but likely these can be compensated for afterwards. The management team of the company is relatively small and few are members of any risk group. Most of our work can be performed from home offices. Laboratory work is currently allowed to continue in Finland. Production of our drug has been completed. Most of our costs are outsourced, giving us flexibility should the global situation worsen. We will stay vigilant and modify our plans as needed.

Latest News

Upcoming Events

Please contact our business development team to meet us at the following events:

13-17th September 2024
ESMO Congress 2024
Barcelona, Spain
17-19th September 2024
Nordic Life Science Days (NLSDays)
Malmö, Sweden
27-30th October 2024
16th Annual International Oncolytic Virotherapy Conference
Rotterdam, Netherlands
4-6th November 2024
BIO-Europe
Stockholm, Sweden
20-21st November 2024
SLUSH
Helsinki, Finland
11-13th December 2024
ESMO Immuno-Oncology Congress
Geneva, Switzerland
13-15th January 2025
Biotech Showcase
San Francisco (CA), USA